One of the perspective methods of cancer chem other apy is magnetic targeting of drugs to tumors. This task is usually accomplished using small perm anent magnets attached near the desired sites. In this study a new much more effective approach is proposed which is based on a strong magnetic gradient using a ferrom agnetic wire placed in a strong magnetic field. Feasibility of this ap proach has been evaluated by the form ation of ferrofluid seals and m easurem ent of maximum pressure the formed seal can resists. Using this m ethod it is possible to capture even superparamagnetic particles with nanos ize dimensions, therefore the m ethod may have an inter esting applications in biomedical sciences.
Introduction
Due to the limitations of currently available chem otherapeutic methods, the delivery of anti cancer drugs to the target site represent a very attractive treatm ent approach, which can substan tially increase therapeutic efficacy and reduce toxic side effects in the treatm ent of solid tumors. One of the promising concepts is magnetic targeting. Using large unilam ellar liposomes with encapsulated ferrofluid we have recently achieved a 26-fold increase of drug concentration in the left kidney of the rat to which a small SmCo magnet was attached compared with the non-targeted right kidney (Babincovä et al., 2000) .
A nother im portant factor which enhance the ef fect of chem otherapy is embolization, or in the other words, mechanical obstruction of tum or due to the enhanced concentration of ferrofluids in the tumor-feeding vessels and the succesive necrosis of tum or body. M oreover ferrofluids obstructing feeding vessels represents barrier which delay out flow of activated drug and minimize further ad verse effects of a drug on healthy tissues.
The force exerted on a magnetisable particle is determ ined by the absolute value and direction of the gradient of the induction of magnetic field I f (Svoboda, 1987) 
Vo where V is the volume and x susceptibility of mag netic particle, and |i0 is the magnetic permeability in vacuum. From this expression it is clear that both magnetic induction as well as its gradient should be maximised. To achieve this goal a highgradient magnetic separation (HGM S) technique was developed. The typical HGM S device consists of a steel-wool matrix m agnetised by an external field (Parker, 1976) . A nother successful approach consists in placing a ferromagnetic wire parallel to the flow tube (Badescu et al., 1996) . O ur aim in this study was to evaluate the suitability of such a m ethod for magnetic drug targeting and tum or embolization.
Material and Methods
We have used four kinds of ferrofluids. Small unilamellar magnetoliposomes (De Cuyper and Joniau, 1988) with the diam eter of 20 nm (SUM), fluidMAG (Chemicell, Berlin, Germ any) of 100 nm, large unilamellar magnetoliposomes (Babincovä, 1993) with 700 nm (LUM ), and bead-MAG (Chemicell, Berlin, Germ any) with 1000 nm. The experim ental setup for the study of seal formation under the influence of non-homogeneous magnetic field is shown in Fig. 1 . A plastic tube (inner diam eter 1.5 mm) is going through a peristaltic pump (flow rate 1 ml/min). The maxi mum pressure that the formed seal can resist is m easured using a pressure gauge m ade from verti cal transparent tube, and from the height h at tained the pressure is calculated as P =Qfiuidgh/QHg> where Qfiuid and QHg are densities of the used fluid and of mercury, respectively (Sheng et al., 1999) .
The magnetic field was generated using a watercooled electromagnet with a 2 x 8 x 17 cm gap, with ferromagnetic wires of 2 cm length and 
Results and Discussion
W hen the maximum resistant pressure was reached, the ferrofluid seal was broken and the pressure dropped to the initial value. Dependence of this maximal pressure on the strength of magnetic field created by electromagnet is shown in Fig. 2 . The maximal pressures which are able to withstand the seals formed from larger particles are substan tially higher and their time of formation is substan- tially shorter (approx. seconds) as compared with small ferrofluid particles (formed in min), and moreover the induction of applied magnetic field should be in this case stronger than 0.5-0.6 T. It should be emphasized that using perm anent mag nets (or electromagnets without the wire) is possible to form a seal only using LUM or beadMAG. For the small superparam agnetic SUM and fluidMAG particles is necessary to use high-gradient magnetic technique. The field gradient VB created by the fer romagnetic wire with saturation magnetization M s = 1.8 T and radius a -1 mm is may be estimated using the approximate formula (Svoboda, 1987) \7B= M s/ a -1.8 . 103 T/m, which is almost a four magnitude larger than the gradient generated near the surface of a small perm anent magnet (Babincovä et al, 2000) . Therefore the force acting on the ferrofluid particles flowing in the plastic tube simulating the blood network is sufficient to induce seal formation. Sealing of blood vessels supplying the tumors (em bolization) would induce tum or necrosis, and m ore over ferrofluid particles may be efficiently heated using a high-frequency magnetic field (Neel and Brown effects, Babincovä et al., 1999) which also may be useful for tum or eradication. Clinical wholebody magnetic resonance imaging machines (M RI) are generating magnetic fields with induction of -1.5 T (research MRI machines with induction > 5 T are also available). Using ferromagnetic wires mounted near the desired sites (e.g. tumors) ferrofluids (carrying anticancer drugs, ß-emitting iso topes, etc.) may be targeted with an efficiency 3 -5 magnitudes larger than using permanent magnets. Our preliminary (unpublished) experiments with the high-gradient magnetic targeting of ferrofluids to a given site of a rat tail seems to support the appli cability of this approach in vivo. Our main topical goal is to develop this technique for a magnetic sitespecific gene targeting using recently synthesized transM AG ferrofluid particles (Chemicell, Berlin, Germany).
